Hodges Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Hodges Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,790	Closed	-$1.39M	–	246
2021 Q1	$1.39M	Sell	15,790 -1,038	-6%	-$96.5K	0.19%	120
2020 Q4	$1.61M	Sell	16,828 -3,760	-18%	-$388K	0.25%	111
2020 Q3	$2.34M	Sell	20,588 -26,207	-56%	-$2.75M	0.45%	76
2020 Q2	$4.63M	Sell	46,795 -21,567	-32%	-$1.72M	0.95%	32
2020 Q1	$4.4M	Sell	68,362 -4,263	-6%	-$299K	1.12%	26
2019 Q4	$4.33M	Sell	72,625 -40,045	-36%	-$2.47M	0.57%	61
2019 Q3	$6.64M	Sell	112,670 -110	-0.1%	-$7.02K	0.77%	39
2019 Q2	$7.28M	Buy	112,780 +103,780	+1,153%	+$6.7M	0.79%	44
2019 Q1	$571K	Sell	9,000 -1,000	-10%	-$52.5K	0.06%	152
2018 Q4	$380K	Buy	+10,000	New	+$353K	0.04%	185

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Hodges Capital Management's TNDM Position: Q2 2021 in Review

Hodges Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 15,790 shares — an estimated $1.39M sold.

Hodges Capital Management first reported a position in TNDM in Q4 2018 and held it in 10 quarters. The position peaked at $7.28M in Q2 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Hodges Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Hodges Capital Management sold 15,790 Tandem Diabetes Care shares in Q2 2021, an estimated $1.39M.
Hodges Capital Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 10 quarters.
Hodges Capital Management's Tandem Diabetes Care position peaked at $7.28M in Q2 2019.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Hodges Capital Management's 13F filing for Q2 2021, filed 6 Jul 2021.